SK&F 95654-Induced Acute Cardiovascular Toxicity in Sprague-Dawley Rats—Histopathologic,Electron Microscopic,and Immunohistochemical Studies

Abstract

The characteristics and pathogenesis of the cardiovascular toxicity induced by the type III selective phosphodiesterase inhibitor SK&F 95654 were examined in 2 studies. Sprague—Dawley rats received either a single sc injection of 50, 100, or 200 mg/kg SK&F 95654 and were euthanized at 24 hours after administration of the drug (Study 1), or were given a single subcutaneous (sc) injection of 100 mg/kg SK&F 95654 and euthanized at 1, 2, 4, 6, 8, 12, 24 hours, or 2 weeks after treatment (Study 2). Control rats received either DMSO or saline. Myocardial lesions and vascular lesions of the mesentery, spleen, and pancreas were seen 24 hours after dosing with either 50, 100, or 200 mg/kg SK&F 95654. The frequency and severity of these lesions (evaluated after the 100 mg/kg dose) increased with time over a period of 1 to 24 hours. By 2 weeks, the lesions subsided. Cardiac lesions consisted of myocyte necrosis with hypercontraction bands, inflammatory cell infiltration, interstitial hemorrhage, and interstitial edema. Vascular lesions of the mesentery were most prominent and consisted of vasodilatation and inflammation in the small-sized vessels, arterial medial necrosis and hemorrhage, and venous thrombosis. The vascular lesions included: leukocyte adhesion to endothelial cells, transendothelial migration of leukocytes, and inflammatory cell infiltration into vessel walls. Affected vessels included arteries, terminal arterioles, capillaries, postcapillary venules, and veins. Apoptosis of endothelial and smooth muscle cells was detected in the mesenteric vasculature by both TUNEL assay and electron microscopy. Evidence of endothelial cell activation in the mesenteric arteries and veins was also observed by electron microscopy. Immunohistochemical staining detected enhanced endothelial cell expression of intercellular adhesion molecule-1 (ICAM-1) and von Willebrand factor (vWF) in the mesenteric arteries and veins. Mast cells were noted to be more prevalent in affected mesenteric tissue from drug-treated animals. The present findings suggest that apoptosis of endothelial and smooth muscle cells, activation of endothelial cells, recruitment of mast cells, and increased expression of adhesion molecules are important factors to the overall pathogenesis of SK&F 95654-induced vasculitis.

Keywords

Myocardial necrosis and inflammation drug-induced vasculitis vasodilatation endothelial cell activation endothelial and smooth muscle cell apoptosis intercellular adhesion molecule-1 (ICAM-1)von Willebrand factor mast cell degranulation.

References

Balazs T. , Payne EJ (1971). Myocardial papillary muscle necrosis induced by hypotensive agents in dogs. Toxicol Appl Pharmacol 20: 442—445.

Bouchama A. , Hammami MM , Haq A. , Jackson J. , Al-Sedairy S. (1996). Evidence for endothelial cell activation/injury in heatstroke. Crit Care Med 24: 1173—1178.

Butthep P. , Bunyaratvej A. , Funahara Y. , Kitaguchi H. , Fucharoen S. , Sato S. , Bhamarapravati N. (1997). Possible evidence of endothelial cell activation and disturbance in thalassemia: An in vitro study. SoutheastAsian J Trop Med Public Health 28: 141—148A.

Cheng W. , Li B. , Katstura J. , Li P. , Wolin MS , Sonnenblick EH , Hintze TH , Olivetti G. , Anversa P. (1995). Stretch-induced programmed myocyte cell death . J Clin Invest 96: 2247—2259.

Cotran RS (1987). New roles for the endothelium in inflammation and immunity. Am J Pathol 129: 407—413.

Dogterom P. , Zbinden G. (1992). Cardiotoxicity of vasodilators and positive inotropic/vasodilating drugs in dogs: An overview. Crit Rev Toxicol 22: 203—241.

Edwards YS , Sutherland LM , Murray AW (2000). NO protects alveolar type II cells from stretch-induced apoptosis. A novel role for macrophages in the lung. Am J Physiol Lung Mol Physiol 279: 1236—1242.

Frijns CJM , Kappelle LJ , van Gijn J. , Nieuwenhuis HK , Sixma JJ , Fijnheer R. (1997). Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis . Stroke 28: 2214—2218.

Fujimura M. , Kamio Y. , Myou S. , Hashimoto T. , Matsuda T. (1997). Effect of a phosphodiesteras e 3 inhibitor, cilostazol, on bronchial hyperresponsivenes s in elderly patients with asthma. Int Arch Allergy Immunol 114: 379—384.

10.

Harleman JH , Joseph EC , Eden RJ , Walkee TF , Major IR , Lamb MS ( 1986). Cardiotoxicity of a new inotrope/vasodilator drug (SK&F 94120) in the dog. Arch Toxicol 59: 51—55.

11.

Hara M. , Matsumori A. , Ono K. , Kido H. , Hwang M-W. , Miyamoto T. , Iwasaki A. , Okada M. , Nakatani K. , Sasayama S. (1999). Mast cells cause apoptosis of cardiomyocyte s and proliferation of other intramyocardial cells in vitro. Circulation 100: 1443—1449.

12.

Hayashi S. , Morishita R. , Higaki J. , Tomita N. , Ogihara T. (1997). Inhibition of growth of human aortic vascular smooth muscle cells by a phosphodiesteras e type 3 inhibitor, cilostazol, through p53-mediated apoptosis. Atherosclerosis 134: 257.

13.

Hébert M. , Gullans SR , Mackenzie HS , Brady HR (1998). Apoptosis of endothelial cells is associated with paracrine induction of adhesion molecules: Evidence for an interleukin-1β-dependent paracrine loop. Am J Pathol 152: 523—532.

14.

Herman EH , Balazs T. , Young R. , Earl FL , Krop S. , Ferrans VJ (1979) Acute cardiomyopathy induced by the vasodilating antihypertensive agent minoxidil. Toxicol Appl Pharmacol 47: 493—503.

15.

Hipper A. , Isenberg G. (2000). Cyclic mechanical stretch decreases DNA synthesis of vascular smooth muscle cells (2000). Pflugers Arch 440: 19— 27.

16.

Hunt BJ , Jurd KM ( 1998). Endothelial cell activation: A central pathophysiological process. BMJ 316: 1328—1329.

17.

Issacs KR , Joseph EC , Betton GR (1989). Coronary vascular lesions in dogs treated with phosphodiesteras e III inhibitors. Toxicol Pathol 17: 153—163.

18.

Jennette JC , Falk RJ (1997). Small-vessel vasculitis . N Engl J Med 20: 1512—1523.

19.

Jennette JC , Falk RJ , Andrassy K. , Bacon PA , Churg J. , Gross WL , Hagen GEC , Hoffman GS , Hunder GG , Kallenberg CGM , McCluskey RT , Sinico RA , Rees AJ , van ESLA , Waldheer R. , Wiik A. (1994). Nomenclature of systemic vaculitides: Proposal of an international consensus conference. Arthritis Rheum 37:187—192.

20.

Jiang X. , Li J. , Paskind M. , Epstein PM (1996). Inhibition of calmodulindependent phosphodiesteras e induces apoptosis in human leukemic cells. Proc Natl Acad Sci USA 93: 11236—11241.

21.

Joseph EC , Jones HB , Kerns WD (1996). Characterization of coronary arterial lesions in the dog following administration of SK&F 95654, a phosphodiesteras e III inhibitor. Toxicol Pathol 24: 429—435.

22.

Joseph EC , Mesfin G. , Kerns WD (1997). Pathogenesis of arterial lesions caused by vasoactive compounds in laboratory animals. In: Comprehensive Toxicology, Vol 6, Cardiovascular Toxicology, Bishop SP , and Kerns WD (eds). Pergamon, New York, pp 279—307.

23.

Joseph EC , Rees JA , Dayan AD (1996). Mesenteric arteriopathy in the rat induced by phosphodiesterase III inhibitors: An investigation of morphological, ultrastructural, and hemodynamic changes. Toxicol Pathol 24: 436—450.

24.

Jurd KM , Stephens CJM , Black MM , Hunt BJ ( 1996). Endothelial cell activation in cutaneous vasculitis. Clin Exp Dermatol 21: 28—32.

25.

Kubes P. , Kanwar S. (1994). Histamine induces leukocyte rolling in post-capillary venules: A P-selectin-mediated event. JImmunol 152: 3570—3577.

26.

Levin S. , Bucci TJ , Cohen SM , Fix AS , Hardisty JF , LeGrand EK , Maronpot RR , Trump BF (1999). The nomenclature of cell death: Recommendations of an ad hoc committee of the society of toxicologic pathologists. Toxicol Pathol 27: 484—490.

27.

Lovelace CIP , Zhang J. , Vanek PG , Collier GB (1996). Detecting apoptotic cells in situ. Biomed Prod 21: 76—77.

28.

Marko D. , Romanakis K. , Zankl H. , Furstenberger G. , Steinbauer B. , Eisenbrand G. (1998). Induction of apoptosis by an inhibitor of cAMPspecific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts. Cell Biochem Biophys 28: 75—101.

29.

Mayr M. , Li C. , Zou Y. , Huemer U. , Hu Y. , Xu Q. (2000). Biomechanical stressinduced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J 14: 261—270.

30.

McConkey DJ , Orrenius S. , Jondal M. (1990). Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J Immunol 145: 1227—1230.

31.

McNeil HP (1996). The mast cell and inflammation . Aust NZ J Med 26: 216—225.

32.

Menas JR , Franklin RB , Sandusky GE (1989). Toxicological evaluation of the cardiotonic isomazole in the dog. Fundam Appl Toxicol 13: 418—428.

33.

Mentz F. , Merle-Beral H. , Dalloul AH (1999). Theophylline-induced B-CLL apoptosis is partially dependent on cyclic AMP production but independent of CD38 expression and endogenous IL-10 production. Leukemia 13: 78—84.

34.

Miyajima A. , Chen J. , Poppas DP , Vaughan ED Jr , Felsen D. (2001). Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction . Kidney Int 59: 1290—1303.

35.

Pober JS (1988). Cytokine-mediated activation of vascular endothelium: Physiology and pathology. Am J Pathol 133: 426—433.

36.

Sandusky GE , Franklin RB , Means JR (1989). Acute, subchronic, and chronic toxicity of the cardiotonic isomazole in rats . Fundam Appl Toxicol 13: 409—417.

37.

Sandusky GE , Means JR , Yeager HK (1993). Coronary artery toxicity in beagle dogs given indolidan, a type III phosphodiesterase inhibitor. Fundam Appl Toxicol 21: 228—235.

38.

Sandusky GE , Vodicnik MJ , Tamura RN (1991). Cardiovascular and adrenal proliferative lesions in Fisher 344 rats induced by long-term treatment with type III phosphodiesteraseinhibitors (positive inotropic agnets), isomazole and indolidan. Fundam Appl Toxicol 16: 198—209.

39.

Stratton RJ , Coghlan JG , Pearson JD , Burns A. , Sweny P. , Abraham DJ , Black CM (1998). Different patterns of endothelial cell activation in renal and pulmonary vascular diseases in scleroderma . Q JMed 91: 561—566.

40.

Torphy TJ , Undem BJ (1991). Phosphodiesterase inhibitors: New opportunities for the treatment of asthma. Thorax 46: 512—523.

41.

Tromp SC , Tangelder GJ , Slaaf DW , Reneman RS , van Velzen S. , Engels W. , van Breda E. , oude Egbrink MGA (1998). The role of mast cells and histamine in leukocyte-endothelium interactions in four rat strains. Pflugers Arch-Eur J Physiol 436: 255—261.

42.

Vintermyr OK , Gjertsen BT , Lanotte M. , Doskeland SO (1993). Microinjected catalytic subunit of cAMP-dependent protein kinase induces apoptosis in myeloid leukemia (IPC-81) cells. Exp Cell Res 206: 157—161.

43.

Vischer UM , Emeis JJ , Bilo HJG , Stehouwer CDA , Thomsen C. , Rasmussen O. , Hermansen K. , Wollheim CB , Ingerslev J. (1998). von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: Improved reliability with parallel determination of the vWf propeptide (vWf:AgII). Thromb Haemost 80: 1002—1007.

44.

Westwood FR , Iswaran TJ , Greaves P. (1990). Pathologic changes in blood vessels following administration of an inotropic vasodilator (ICI 153, 110) to the rat. Fundam Appl Toxicol 14: 797—809.

45.

Zychlinsky A. , Sansonnetti PJ (1997). Apoptosis as proinflammatory event: What can we learn from bacteria-induced cell death ? Trends Microbiol 5: 201—204.